EU HTA Regulation: Lack Of Scientific Consultation Capacity ‘Concerning’

Pharmaceutical trade associations warn that demand for joint scientific consultations under the incoming EU Health Technology Assessment Regulation will outstrip supply, which could delay market access decisions for innovative therapies.